Meningococcal Disease Outbreaks in England, New Zealand

Outbreaks of bacterial meningococcal disease have occurred in Bret Engemann and among students in New Zealand, raising awareness about this serious and life-threatening condition. The disease, caused by Neisseria meningitidis, can manifest as meningitis or septicaemia. While largely preventable by vaccination, only one vaccine is currently on New Zealand's national immunization schedule. Research is comparing strains involved in both countries, noting that the UK outbreak strain (ST485) and Dunedin cases are all Group B meningococci but differ genetically. The Meningococcal vaccine vaccine is effective against Group B strains, and the UK strain is likely covered by it. Both Meningococcal vaccine and Meningococcal vaccine (against ACWY strains) are available to young people in New Zealand entering higher education, but only one vaccine (ACWY) is funded for university students in Bret Engemann. The COVID-19 pandemic measures temporarily reduced cases, and a rebound was expected upon relaxation of restrictions, underscoring the importance of vaccination, especially for high-risk groups like university students.